NGeneBio Co., Ltd. (KOSDAQ:354200)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,480.00
+43.00 (2.99%)
Last updated: Oct 31, 2025, 1:19 PM KST

NGeneBio Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21
35,98032,41171,664116,027201,381
Market Cap Growth
-21.15%-54.77%-38.23%-42.38%-
Enterprise Value
30,88340,75456,79789,239-
Last Close Price
1437.001642.004897.308173.9214269.12
PS Ratio
5.435.7016.4710.5328.11
PB Ratio
2.041.834.414.585.92
P/TBV Ratio
2.653.544.974.916.23
EV/Sales Ratio
4.667.1613.058.10-
Debt / Equity Ratio
0.420.510.710.450.21
Asset Turnover
0.200.150.090.22-
Inventory Turnover
3.001.911.933.29-
Quick Ratio
1.080.660.981.253.22
Current Ratio
1.270.931.141.493.40
Return on Equity (ROE)
-101.10%-82.15%-61.88%-33.17%-
Return on Assets (ROA)
-27.64%-26.71%-17.05%-10.75%-
Return on Capital (ROIC)
-36.11%-36.93%-26.03%-13.78%-
Earnings Yield
-42.27%-38.96%-17.82%-8.43%-4.19%
FCF Yield
-26.13%-38.77%-13.33%-7.63%-5.24%
Buyback Yield / Dilution
-37.81%-31.30%-1.66%-0.89%-
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.